Literature DB >> 1875144

Rhinocerebral mucormycosis: use of liposomal amphotericin B.

E W Fisher1, A Toma, P H Fisher, A D Cheesman.   

Abstract

Rhinocerebral mucormycosis is a rare but often fatal condition characterized by an aggressive necrotizing infection spreading from the nose to the paranasal sinuses, orbit and hence to the central nervous system. A case is reported in which a diabetic male with advanced mucormycosis was successfully treated by a combination of surgery, supportive therapy and liposomal amphotericin B. Liposomal delivery allows the drug to be both less toxic and more effective, and this is the first reported case of its use in rhinocerebral mucormycosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875144     DOI: 10.1017/s0022215100116652

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  17 in total

1.  Right ear pain and neck swelling.

Authors:  H Kirkpatrick; R E Jones; V Wadlington; J M Gilsoul
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-04

2.  Acute invasive fungal rhinosinusitis: our experience with 19 patients.

Authors:  Ahmet Emre Süslü; Oğuz Oğretmenoğlu; Nilda Süslü; Omer TaşkIn Yücel; Tevfik Metin Onerci
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-10       Impact factor: 2.503

Review 3.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 4.  Lipid formulations of amphotericin B. Less toxicity but at what economic cost?

Authors:  J Tollemar; O Ringdén
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Rhinocerebral mucormycosis: pathways of spread.

Authors:  Seid Mousa Sadr Hosseini; Peyman Borghei
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-13       Impact factor: 2.503

Review 7.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

8.  Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy.

Authors:  Saroj Gupta; Rashmi Goyal; Navinchandra M Kaore
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-12-05

9.  Treatment of deep mycoses with liposomal amphotericin B.

Authors:  J Berenguer; P Muñoz; F Parras; V Fernández-Baca; T Hernández-Sampelayo; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

10.  Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer.

Authors:  W Emminger; W Graninger; W Emminger-Schmidmeier; A Zoubek; K Pillwein; M Susani; A Wasserer; H Gadner
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.